Multiple sclerosis (MS) is a disease where the majority of people are diagnosed in early adulthood however they experience a long sequela, with chronic progressive deterioration in most cases and a median survival time of 35-42 years. The increasing levels of disability reduce the individual’s potential to work fully and in time their ability to perform their activities of daily living. As these patients are affected in their most productive years the resulting impact on their health, employment and social status means that there is likely to be a large socioeconomic cost to the individual, their families, and those countries with a high prevalence of multiple sclerosis. In 2006 the New Zealand National MS Prevalence Study (NZNMSPS) was ...
This thesis presents results of a prevalence survey and longitudinal cohort study (2002 to 2005) of ...
Objective: This study is the first to assess if the National Disability Insurance Scheme (NDIS) pack...
Objective: The objective of this paper is to investigate demographic and disease factors associated ...
Multiple sclerosis (MS) is a disease where the majority of people are diagnosed in early adulthood h...
Objective To examine the association between socioeconomic status (SES) and disability outcomes and ...
International audienceBACKGROUND:Little is known about the association between the socioeconomic sta...
Multiple Sclerosis (MS) is a disease with a complex aetiology and pathogenesis. It is the most commo...
International audienceBackgroundThe effects of socio-economic status on mortality in patients with m...
Background: Disease-modifying therapies (DMTs) are used to treat people with relapsing-onset multipl...
Multiple Sclerosis (MS) is the most common demyelinating disease of the Central Nervous System. It i...
Multiple sclerosis (MS) is a chronic neurodegenerative disease, with a mean age of onset between 30-...
This study used quantitative and qualitative techniques to examine the role of health, age, and dura...
This thesis presents results of a prevalence survey and longitudinal cohort study (2002 to 2005) of ...
Objective: This study is the first to assess if the National Disability Insurance Scheme (NDIS) pack...
Objective: The objective of this paper is to investigate demographic and disease factors associated ...
Multiple sclerosis (MS) is a disease where the majority of people are diagnosed in early adulthood h...
Objective To examine the association between socioeconomic status (SES) and disability outcomes and ...
International audienceBACKGROUND:Little is known about the association between the socioeconomic sta...
Multiple Sclerosis (MS) is a disease with a complex aetiology and pathogenesis. It is the most commo...
International audienceBackgroundThe effects of socio-economic status on mortality in patients with m...
Background: Disease-modifying therapies (DMTs) are used to treat people with relapsing-onset multipl...
Multiple Sclerosis (MS) is the most common demyelinating disease of the Central Nervous System. It i...
Multiple sclerosis (MS) is a chronic neurodegenerative disease, with a mean age of onset between 30-...
This study used quantitative and qualitative techniques to examine the role of health, age, and dura...
This thesis presents results of a prevalence survey and longitudinal cohort study (2002 to 2005) of ...
Objective: This study is the first to assess if the National Disability Insurance Scheme (NDIS) pack...
Objective: The objective of this paper is to investigate demographic and disease factors associated ...